| Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 179.63 mm | 179.63 mm | 179.63 mm | 179.63 mm | 179.63 mm | 179.63 mm |
| Cash burn (monthly) | (no burn) | (no burn) | (no burn) | 8.92 mm | (no burn) | 4.83 mm |
| Cash used (since last report) | n/a | n/a | n/a | 35.90 mm | n/a | 19.44 mm |
| Cash remaining | n/a | n/a | n/a | 143.73 mm | n/a | 160.18 mm |
| Runway (months of cash) | n/a | n/a | n/a | 16.1 | n/a | 33.1 |
| 13F holders | Current |
|---|---|
| Total holders | 125 |
| Opened positions | 16 |
| Closed positions | 37 |
| Increased positions | 38 |
| Reduced positions | 45 |
| 13F shares | Current |
|---|---|
| Total value | 178.77 bn |
| Total shares | 66.21 mm |
| Total puts | 238.30 k |
| Total calls | 214.80 k |
| Total put/call ratio | 1.1 |
| Largest owners | Shares | Value |
|---|---|---|
| BBBOF BB Biotech | 9.93 mm | $0.00 |
| BLVGF Bellevue | 9.93 mm | $32.67 bn |
| Armistice Capital | 6.26 mm | $20.59 bn |
| BlackRock | 5.41 mm | $17.78 bn |
| Vanguard | 4.36 mm | $14.34 bn |
| Millennium Management | 3.54 mm | $11.63 bn |
| Frazier Life Sciences Management | 3.01 mm | $9.91 bn |
| Wasatch Advisors | 2.54 mm | $8.34 bn |
| STT State Street | 1.43 mm | $4.70 bn |
| Geode Capital Management | 1.41 mm | $4.63 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 7 Oct 24 | Koenig Scott | Common Stock | Gift | Acquire G | Yes | No | 0 | 53,265 | 0.00 | 427,480 |
| 7 Oct 24 | Koenig Scott | Common Stock | Gift | Dispose G | No | No | 0 | 53,265 | 0.00 | 0 |
| 23 Sep 24 | Koenig Scott | Common Stock | Gift | Acquire G | Yes | No | 0 | 374,215 | 0.00 | 374,215 |
| 23 Sep 24 | Koenig Scott | Common Stock | Gift | Dispose G | No | No | 0 | 374,215 | 0.00 | 703,413 |
| 21 May 24 | Margaret Liu | Stock Option Common Stock | Grant | Acquire A | No | No | 4.26 | 16,500 | 70.29 k | 16,500 |
| 21 May 24 | Margaret Liu | RSU Common Stock | Grant | Acquire A | No | No | 0 | 6,500 | 0.00 | 6,500 |
| 21 May 24 | Margaret Liu | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 4.26 | 16,500 | 70.29 k | 16,500 |
| 21 May 24 | Siegel Jay Philip | Stock Option Common Stock | Grant | Acquire A | No | No | 4.26 | 16,500 | 70.29 k | 16,500 |
| 21 May 24 | Siegel Jay Philip | RSU Common Stock | Grant | Acquire A | No | No | 0 | 6,500 | 0.00 | 6,500 |
